The clinical relevance of antibodies to ribosomal-P common epitope in two targeted systemic lupus erythematosus populations: A large cohort of consecutive patients and patients with active central nervous system disease

Annals of the Rheumatic Diseases

Volumn 59, Issue 2, 2000, Pages 99-104

  Tzioufas, A G ^a   Tzortzakis, N G ^a   Panou Pomonis, E ^b   Boki, K A ^a   Sakarellos Daitsiotis, M ^b   Sakarellos, C ^b   Moutsopoulos, H M ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF IOANNINA   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; RIBOSOME PROTEIN;

ADULT; ANTIBODY DETECTION; ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ANIMALS; AUTOANTIBODIES; AUTOIMMUNE DISEASES; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; COHORT STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS VASCULITIS, CENTRAL NERVOUS SYSTEM; MALE; PROTOZOAN PROTEINS; RATS; RIBOSOMAL PROTEINS; SENSITIVITY AND SPECIFICITY;

EID: 0034026968     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.59.2.99     Document Type: Article

References (32)

1. 1 Elkon KB, Parnassa AP, Foster CL. Lupus autoantibodies target ribosomal P proteins. J Exp Med 1985;162:459-71.
2. 2 Francoeur A-M, Peebles CI, Heckman KJ, Lee JC, Tan EM. Identification of ribosomal protein autoantigens. J Imununol 1985;135:2378-84.
3. 3 Elkon K Skelly S, Parnassa A, Maller W Danho W, Weissbach H, Brot N. Identification and chemical synthesis of a ribosomal protein antigenic determinant in systemic lupus erythematosus. Proc Natl Acad Sci USA 1986;83: 7419-23.
4. 4 Teh L-S, Isenberg DA. Antiribosomal P protein antibodies in systemic lupus erythematosus. A reappraisal. Arthritis Rheum 1994;37:307-15.
5. 5 Arnett FC, Reveille JD, Moutsopoulos HM, Georgescu L, Elkon KB. Ribosomal P autoantibodies in systemic lupus erythematosus. Arthritis Rheum 1996;39:1833-9.
6. 6 Alarcon-Segovia D, Perez-Vazquez ME, Villa AR, Drenkard C, Cabiedes J. Preliminary classification criteria for the antiphospholipid syndrome within systemic lupus erythematosus. Semin Arthritis Rheum 1992;21: 275-86.
7. 7 Manoussakis MN, Tzioufas AG, Silis M, Pange PJE, Goudevenos J, Moutsopoulos HM. High prevalence of anticardiolipin and other autoantibodies in a healthy elderly population. Clin Exp Immunol 1987;69:557-65.
8. 8 Tan EM, Cohen AS, Fries JF, Masi AT, Mcshane DJ Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus Arthritis Rheum 1982;25:1271-7.
9. 9 Faumann MA. Study guide to DSM-IV. Washington DC: American Psychiatric Association, 1994.
10. 10 West SG. Neuropsychiatric lupus. Rheum Dis Clin North Am 1994;20:129-58.
11. 11 Tzioufas AG, Manoussakis MN, Drosos AA, Silis G, Gharavi AG, Moutsopoulos HM. Enzyme immunoassays for the detection of IgG and IgM anti ds DNA antibodies: clinical significance and specificity. Clin Exp Rheumatol 1987;5: 247-53.
12. 12 Meilof JF, Bantjes I, DeJong J, Van Dam AP, Smeenk RJT. The detection of anti Ro/SSA and anti La/SSB antibodies. A comparison of counterimmunoelectrophoresis with immunoblot, ELISA and RNA-precipitation assays. J Immunol Methods 1990;133:215-26.
13. 13 Vitali C, Bencivelli W, Isenberg DA Smolen JC, Snaith ML, Sciuto M and the European Consensus study Group for Disease Activity in SLE. Disease activity in systemic lupus erythematosus: report of rheumatology research. II. Identification of the variables indicative of disease activity and their use in the development of an activity score. Clin Exp Rheumatol 1992;10:541-7.
14. 14 Arnett FC, Edworthy S.M, Bloch DA, et al. The American Rheumatism Association 1987, revised criteria or the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31:315-24.
15. 15 Vitali C, Bombardieri S, Moutsopoulos H.M, et al. Preliminary criteria for the classification of Sjögren's syndrome. Arthritis Rheum 1993;36:340-7.
16. 16 Merifield RB. Solid phase peptide synthesis. I. The synthesis of a tetrapeptide. JACS 1963;85:2149-54.
17. 17 Stewart JM, Young JD, eds. Solid phase peptide synthesis. Rokcford: Pierce Chemical Co, 1984.
18. 18 Caponi L, Pegorano S, Di Bartolo V, Rovero P, Revoltella R, Bombardieri S. Autoantibodies directed against ribosomal P proteins: use of a multiple antigen peptide as the coating agent in ELISA. J Immunol Methods 1995;179:193-202.
19. 2 protein in patients with systemic lupus erythematosus. J Clin Invest 1994;94:345-52.
20. 20 Bonfa E, Weissbach H, Brot N Elkon KB. Ribosomal protein autoantibodies. Peter JB, Shoenfeld Y, eds. Autoantibodies. Amsterdam: Elsevier sciences BV, 1996:721-6.
21. 21 Schneebaum AB, Singleton JD, Kotzin BL. Association of psychiatric manifestations with antibodies to ribosomal P proteins in systemic lupus erythematosus. Am J Med 1990; 90:54-62.
22. 22 Bonfa E, Gaburo Junior N, Tavares AV, Cossermelli N. Comparison of five methods for the detection of antiribosomal P protein antibody. Braz J Med Biol Res 1994;27: 637-43.
23. 23 Bonfa E, Golombek SJ Kaufmann LD, Skelly S, Weisbach H, Brot N, et al. Association between lupus psychosis and antiribosomal P protein antibodies. N Engl J Med 1987;317:265-71.
24. 24 Nojima Y, Minota S Yamada A, Takaku F, Aotsuka S Yokohari R. Correlation of antibodies to ribosomal P protein with psychosis in patients with systemic lupus erythematosus. Ann Rheum Dis 1992;51:1053-5.
25. 25 Press J Palayew K, Laxer RM, Elkon KB, Eddy A, Rakoff D, et al. Antiribosomal P antibodies in pediatric patients with systemic lupus erythematosus and psychosis. Arthritis Rheum 1996;99:671-6.
26. 26 Isshi K, Hirohata S. Association of anti-ribosomal P protein antibodies with neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 1996;39:1483-90.
27. 27 Sato T, Uchiumi T Ozawa T, Kikuchi M, Nakano M Kominami R, et al. Autoantibodies against ribosomal protein found with high frequency in patients with systemic lupus erythematosus with active disease. J Rheumatol 1991;18: 1681-4.
28. 28 Van Dam A, Nossent H, de Jong J, Meilof J, Ter-Borg E-J, Swaak T, et al. Diagnostic value of antibodies against ribosomal phosphoproteins: a cross sectional and longitudinal study. J Rheumatol 1991;18:1026-34.
29. 29 Teh I.-S, Bedwell AE, Isenberg DA, Gordon C, Emery, Charles PJ, et al. Antibodies to protein P in systemic lupus erythematosus. Ann Rheum Dis 1992;51:489-94.
30. 30 Yoshio T, Masugama JI, Minota S, Iwamoto M, Mimori A, Takeda A, et al. Correlation of serum IgG antibodies to recombinant Po fusion protein with IgG antibodies to carboxyl-terminal 22 synthetic peptides and carboxyl-terminal 22 aminoacid-deleted recombinant Po fusion protein in patients with systemic lupus erythematosus. Arthritis Rheum 1997;40:1364-5.
31. 31 Hirohata S, Isshi K, Toyoshima S. Association between serum IgG antibodies to recombinant ribosomal P0 fusion protein and neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 1998;41:745-7.
32. 32 Teh L-S, Lee MK, Wang F, Manivasagar M, Charles PJ, Nicholson GD, et al. Antiribosomal P protein antibodies in different populations of patients with systemic lupus erythematosus. Br J Rheumatol 1993;32:663-5.